Formulation and in vitro evaluation of anti-infective dry foams.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003911:Dextrans; D004058:Diffusion; D004338:Drug Combinations / Q000008:administration & dosage; D004355:Drug Stability; D005839:Gentamicins / Q000008:administration & dosage; D006813:Humidity; D009583:Nitrofurazone / Q000008:administration & dosage; D009779:Occlusive Dressings; D009824:Ointments; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012835:Silver Nitrate / Q000008:administration & dosage; D013411:Sulfadiazine / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage*; D013696:Temperature; D014105:Tosyl Compounds / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; D003911:Dextrans; D004338:Drug Combinations; D005839:Gentamicins; D009824:Ointments; D013449:Sulfonamides; D014105:Tosyl Compounds; D013411:Sulfadiazine; D012835:Silver Nitrate; D009583:Nitrofurazone